vs

Side-by-side financial comparison of Air Products (APD) and Emerson Electric (EMR). Click either name above to swap in a different company.

Emerson Electric is the larger business by last-quarter revenue ($4.3B vs $3.2B, roughly 1.4× Air Products). Air Products runs the higher net margin — 22.9% vs 13.9%, a 8.9% gap on every dollar of revenue. On growth, Air Products posted the faster year-over-year revenue change (8.8% vs 4.1%). Over the past eight quarters, Air Products's revenue compounded faster (3.1% CAGR vs -0.3%).

Air Products and Chemicals, Inc. provides atmospheric gases, process and specialty gases, equipment, and services worldwide. The company produces atmospheric gases, including oxygen, nitrogen, and argon; process gases, such as hydrogen, helium, carbon dioxide, carbon monoxide, syngas; specialty gases; and equipment for the production or processing of gases comprising air separation units and non-cryogenic generators for customers in various industries, including refining, chemical, gasificati...

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

APD vs EMR — Head-to-Head

Bigger by revenue
EMR
EMR
1.4× larger
EMR
$4.3B
$3.2B
APD
Growing faster (revenue YoY)
APD
APD
+4.7% gap
APD
8.8%
4.1%
EMR
Higher net margin
APD
APD
8.9% more per $
APD
22.9%
13.9%
EMR
Faster 2-yr revenue CAGR
APD
APD
Annualised
APD
3.1%
-0.3%
EMR

Income Statement — Q2 FY2026 vs Q1 FY2026

Metric
APD
APD
EMR
EMR
Revenue
$3.2B
$4.3B
Net Profit
$724.8M
$605.0M
Gross Margin
31.1%
53.2%
Operating Margin
17.8%
Net Margin
22.9%
13.9%
Revenue YoY
8.8%
4.1%
Net Profit YoY
166.6%
3.4%
EPS (diluted)
$3.19
$1.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APD
APD
EMR
EMR
Q1 26
$3.2B
Q4 25
$3.1B
$4.3B
Q3 25
$3.2B
$4.9B
Q2 25
$3.0B
$4.6B
Q1 25
$2.9B
$4.4B
Q4 24
$2.9B
$4.2B
Q3 24
$3.2B
$4.6B
Q2 24
$3.0B
$4.4B
Net Profit
APD
APD
EMR
EMR
Q1 26
$724.8M
Q4 25
$678.2M
$605.0M
Q3 25
$4.9M
$637.0M
Q2 25
$713.8M
$586.0M
Q1 25
$-1.7B
$485.0M
Q4 24
$617.4M
$585.0M
Q3 24
$1.9B
$996.0M
Q2 24
$696.6M
$329.0M
Gross Margin
APD
APD
EMR
EMR
Q1 26
31.1%
Q4 25
32.1%
53.2%
Q3 25
32.3%
51.9%
Q2 25
32.5%
52.6%
Q1 25
29.6%
53.5%
Q4 24
31.2%
53.5%
Q3 24
34.0%
51.3%
Q2 24
32.8%
52.8%
Operating Margin
APD
APD
EMR
EMR
Q1 26
Q4 25
23.7%
17.8%
Q3 25
0.5%
16.4%
Q2 25
26.2%
16.1%
Q1 25
-79.8%
14.2%
Q4 24
22.0%
18.6%
Q3 24
76.1%
14.7%
Q2 24
24.7%
10.4%
Net Margin
APD
APD
EMR
EMR
Q1 26
22.9%
Q4 25
21.9%
13.9%
Q3 25
0.2%
13.1%
Q2 25
23.6%
12.9%
Q1 25
-59.3%
10.9%
Q4 24
21.1%
14.0%
Q3 24
61.2%
21.6%
Q2 24
23.3%
7.5%
EPS (diluted)
APD
APD
EMR
EMR
Q1 26
$3.19
Q4 25
$3.04
$1.07
Q3 25
$0.03
$1.12
Q2 25
$3.20
$1.04
Q1 25
$-7.77
$0.86
Q4 24
$2.77
$1.02
Q3 24
$8.75
$1.74
Q2 24
$3.13
$0.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APD
APD
EMR
EMR
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
$17.4M
$7.6B
Stockholders' EquityBook value
$18.1M
$20.3B
Total Assets
$41.6M
$41.9B
Debt / EquityLower = less leverage
0.96×
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APD
APD
EMR
EMR
Q1 26
Q4 25
$1.0B
Q3 25
$1.9B
Q2 25
$2.3B
Q1 25
$1.6B
Q4 24
$2.0B
Q3 24
$3.0B
Q2 24
$2.4B
Total Debt
APD
APD
EMR
EMR
Q1 26
$17.4M
Q4 25
$7.6B
Q3 25
$8.9B
Q2 25
$8.3B
Q1 25
$8.2B
Q4 24
$6.6B
Q3 24
$7.7B
Q2 24
$7.1B
Stockholders' Equity
APD
APD
EMR
EMR
Q1 26
$18.1M
Q4 25
$15.4B
$20.3B
Q3 25
$15.0B
$20.3B
Q2 25
$15.5B
$19.9B
Q1 25
$14.7B
$19.2B
Q4 24
$16.7B
$20.5B
Q3 24
$17.0B
$21.6B
Q2 24
$15.1B
$20.8B
Total Assets
APD
APD
EMR
EMR
Q1 26
$41.6M
Q4 25
$41.2B
$41.9B
Q3 25
$41.1B
$42.0B
Q2 25
$41.7B
$42.5B
Q1 25
$38.9B
$42.0B
Q4 24
$40.0B
$42.6B
Q3 24
$39.6B
$44.2B
Q2 24
$37.0B
$45.6B
Debt / Equity
APD
APD
EMR
EMR
Q1 26
0.96×
Q4 25
0.37×
Q3 25
0.44×
Q2 25
0.42×
Q1 25
0.42×
Q4 24
0.32×
Q3 24
0.36×
Q2 24
0.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APD
APD
EMR
EMR
Operating Cash FlowLast quarter
$699.0M
Free Cash FlowOCF − Capex
$602.0M
FCF MarginFCF / Revenue
13.9%
Capex IntensityCapex / Revenue
56.4%
2.2%
Cash ConversionOCF / Net Profit
1.16×
TTM Free Cash FlowTrailing 4 quarters
$4.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APD
APD
EMR
EMR
Q1 26
Q4 25
$900.7M
$699.0M
Q3 25
$3.1B
Q2 25
$855.8M
$1.1B
Q1 25
$328.1M
$241.0M
Q4 24
$811.7M
$777.0M
Q3 24
$3.3B
Q2 24
$1.3B
$1.1B
Free Cash Flow
APD
APD
EMR
EMR
Q1 26
Q4 25
$-350.5M
$602.0M
Q3 25
$2.7B
Q2 25
$-640.0M
$977.0M
Q1 25
$-1.6B
$154.0M
Q4 24
$-1.3B
$694.0M
Q3 24
$2.9B
Q2 24
$-345.2M
$998.0M
FCF Margin
APD
APD
EMR
EMR
Q1 26
Q4 25
-11.3%
13.9%
Q3 25
54.9%
Q2 25
-21.2%
21.5%
Q1 25
-53.6%
3.5%
Q4 24
-44.5%
16.6%
Q3 24
63.1%
Q2 24
-11.6%
22.8%
Capex Intensity
APD
APD
EMR
EMR
Q1 26
56.4%
Q4 25
40.3%
2.2%
Q3 25
47.9%
8.9%
Q2 25
49.5%
2.0%
Q1 25
64.9%
2.0%
Q4 24
72.2%
2.0%
Q3 24
65.1%
9.1%
Q2 24
53.8%
2.1%
Cash Conversion
APD
APD
EMR
EMR
Q1 26
Q4 25
1.33×
1.16×
Q3 25
4.86×
Q2 25
1.20×
1.83×
Q1 25
0.50×
Q4 24
1.31×
1.33×
Q3 24
3.35×
Q2 24
1.81×
3.31×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

APD
APD

Segment breakdown not available.

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

Related Comparisons